VCP mutations account for only 1–2% of fALS and have a small role in sALS (Ng et al., 2015), while approximately one third are linked to FTD, Paget’s disease of bone (PDB) and inclusion body myopathy (IBM) (Nalbandian et al., 2011). Here, VCP is linked to inclusion body myositis.